ENANTA PHARMACEUTICALS INC - Common Stock (ENTA)

CUSIP: 29251M106

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 7 signals
Share change
+6,976,111
Put/Call ratio
0%
SEC-reported price per share
$15.77
Number of holders
130
Value change
+$116,200,977
Number of buys
77
Open additional details 1 more signal available
Number of sells
51
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
28,890,574

Security key

29251M106

Report period

Q4 2025

Institutions

130

Top holders

10

Ownership snapshot

Top reported holders of ENTA - ENANTA PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Janus Henderson Group Ltd.
Disclosed value leader
Farallon Capital Partners...
Comparable rows
5/15
Latest evidence
31 Dec 2025
13D/G 13F Lead comparable stake: 12% 10 rows are not safely comparable across share classes. 13D/G row: Janus Henderson Group Ltd. Showing 1-6 of 15 holder rows.

Quick read

Janus Henderson Group Ltd. leads the comparable SEC ownership view at 12%.

5 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Janus Henderson Group Ltd.'s linked filing trail.
Comparable ownership Top 5
Janus Henderson Group Ltd. 12%
Farallon Capital Partners, L.P. 9.8%
BlackRock, Inc. 7.8%
Ph.D. Jay R. Luly 7.7%
INTEGRATED CORE STRATEGIES (US) LLC 2.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Janus Henderson Group Ltd.
13D/G 13F
JANUS HENDERSON GROUP PLC · Company
12%
Reported 13D/G · 31 Oct 2025
$41,823,994
3,494,068 shares
$0 31 Oct 2025
Farallon Capital Partners, L.P.
13D/G
Dapice Joshua J.
9.8%
Reported 13D/G · 31 Dec 2025
$44,421,914
2,816,862 shares
+$11,174,622 31 Dec 2025
BlackRock, Inc.
13F 13D/G
Company
7.8%
Reported 13D/G · 31 Mar 2025
$21,940,770
1,832,980 shares
— 30 Sep 2025
Ph.D. Jay R. Luly
13D/G
Jay R. Luly, Ph.D.
7.7%
Reported 13D/G · 12 Feb 2025
$9,659,503
1,703,616 shares
$0 12 Feb 2025
INTEGRATED CORE STRATEGIES (US) LLC
13D/G
Millennium Management LLC
2.3%
Reported 13D/G · 31 Dec 2025
$10,572,650
670,428 shares
-$7,381,243 31 Dec 2025
FARALLON CAPITAL MANAGEMENT, L.L.C.
13F
Company
13F
—
denominator unverified
$25,403,476
2,122,262 shares
— 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
130
Shares
26,389,999
Rows available
130
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
119
Q4 2025 holders
130
Holder diff
11
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .